Mara Kochaba (Stein)
About Mara Kochaba (Stein)
Mara Kochaba (Stein) serves as the Director of Regulatory Affairs at Wave Life Sciences, bringing extensive experience in regulatory affairs across various companies, including Alkermes and Sanofi Genzyme.
Current Position at Wave Life Sciences
Mara Kochaba serves as the Director of Regulatory Affairs at Wave Life Sciences, a position she has held since 2022. In this role, she leads regulatory initiatives and oversees the approval processes for the company's innovative therapies. Her expertise in regulatory affairs is crucial for navigating the complexities of compliance and ensuring that products meet the necessary standards for patient safety and efficacy.
Previous Experience in Regulatory Affairs
Prior to her current role, Mara Kochaba held several positions in regulatory affairs across various organizations. She worked as Associate Director of Regulatory Affairs at Gemini Therapeutics for six months in 2021-2022. Before that, she spent four years at Sanofi Genzyme, where she held roles including Principal and Manager of Regulatory Affairs. Her extensive background includes experience at Alkermes, where she progressed through multiple roles in regulatory affairs and research.
Education and Academic Background
Mara Kochaba earned her Bachelor of Science degree in Chemistry from Boston College, where she studied from 1990 to 1994. This educational foundation has equipped her with the scientific knowledge necessary for her career in regulatory affairs, particularly in the fields of oncology and neuroscience.
Specialization and Skills
Mara Kochaba specializes in leading cross-functional and multi-cultural teams to achieve regulatory approvals. She focuses on developing straightforward solutions to complex regulatory challenges, particularly under time constraints. Her skills are particularly relevant in the fast-paced environment of life sciences, where regulatory compliance is critical for the success of new therapies.
Career Motivation and Focus
Mara Kochaba is motivated by her work in innovative firms that are dedicated to improving patient lives. Her career reflects a commitment to advancing healthcare through effective regulatory strategies, ensuring that new treatments can reach patients in need while adhering to strict regulatory standards.